Xenetic Biosciences, Inc.XBIONASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank10
Year-over-Year Change
Year-over-year free cash flow growth rate
Percentile
P10
Near historical low
vs 5Y Ago
-3.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -71.50% |
| Q2 2025 | 61.69% |
| Q1 2025 | -48.65% |
| Q4 2024 | -46.83% |
| Q3 2024 | 12.58% |
| Q2 2024 | 54.71% |
| Q1 2024 | -46.19% |
| Q4 2023 | 16.49% |
| Q3 2023 | 25.17% |
| Q2 2023 | -15.12% |
| Q1 2023 | -46.81% |
| Q4 2022 | 30.42% |
| Q3 2022 | -48.07% |
| Q2 2022 | 65.09% |
| Q1 2022 | -43.12% |
| Q4 2021 | -41.16% |
| Q3 2021 | -42.18% |
| Q2 2021 | 52.16% |
| Q1 2021 | -59.30% |
| Q4 2020 | 5.77% |
| Q3 2020 | 22.19% |
| Q2 2020 | -29.98% |
| Q1 2020 | 40.35% |
| Q4 2019 | 30.56% |
| Q3 2019 | -129.91% |
| Q2 2019 | 16.23% |
| Q1 2019 | -20.53% |
| Q4 2018 | 37.60% |
| Q3 2018 | 20.11% |
| Q2 2018 | -25.28% |
| Q1 2018 | -134.45% |
| Q4 2017 | 395.52% |
| Q3 2017 | 17.79% |
| Q2 2017 | -823.20% |
| Q1 2017 | 105.95% |
| Q4 2016 | -349.62% |
| Q3 2016 | 24.31% |
| Q2 2016 | 24.04% |
| Q1 2016 | -60.43% |
| Q4 2015 | 42.95% |